Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa.
Neurology. 2011 Jan 18;76(3):301-3. doi: 10.1212/WNL.0b013e318207b01e.
Neurology. 2011.
PMID: 21242499
No abstract available.
Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?
Lesage S, Belarbi S, Troiano A, Condroyer C, Hecham N, Pollak P, Lohman E, Benhassine T, Ysmail-Dahlouk F, Dürr A, Tazir M, Brice A; French Parkinson's Disease Genetics Study Group.
Lesage S, et al. Among authors: hecham n.
Neurology. 2008 Nov 4;71(19):1550-2. doi: 10.1212/01.wnl.0000338460.89796.06.
Neurology. 2008.
PMID: 18981379
No abstract available.
Item in Clipboard
Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans.
Lesage S, Patin E, Condroyer C, Leutenegger AL, Lohmann E, Giladi N, Bar-Shira A, Belarbi S, Hecham N, Pollak P, Ouvrard-Hernandez AM, Bardien S, Carr J, Benhassine T, Tomiyama H, Pirkevi C, Hamadouche T, Cazeneuve C, Basak AN, Hattori N, Dürr A, Tazir M, Orr-Urtreger A, Quintana-Murci L, Brice A; French Parkinson's Disease Genetics Study Group.
Lesage S, et al. Among authors: hecham n.
Hum Mol Genet. 2010 May 15;19(10):1998-2004. doi: 10.1093/hmg/ddq081. Epub 2010 Mar 2.
Hum Mol Genet. 2010.
PMID: 20197411
Item in Clipboard
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW; International LRRK2 Consortium.
Healy DG, et al.
Lancet Neurol. 2008 Jul;7(7):583-90. doi: 10.1016/S1474-4422(08)70117-0. Epub 2008 Jun 6.
Lancet Neurol. 2008.
PMID: 18539534
Free PMC article.
Item in Clipboard
LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort.
Belarbi S, Hecham N, Lesage S, Kediha MI, Smail N, Benhassine T, Ysmail-Dahlouk F, Lohman E, Benhabyles B, Hamadouche T, Assami S, Brice A, Tazir M.
Belarbi S, et al. Among authors: hecham n.
Parkinsonism Relat Disord. 2010 Dec;16(10):676-9. doi: 10.1016/j.parkreldis.2010.09.003. Epub 2010 Oct 8.
Parkinsonism Relat Disord. 2010.
PMID: 20933457
Item in Clipboard
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.
Vermersch P, Brieva-Ruiz L, Fox RJ, Paul F, Ramio-Torrenta L, Schwab M, Moussy A, Mansfield C, Hermine O, Maciejowski M; AB07002 Study Group.
Vermersch P, et al.
Neurol Neuroimmunol Neuroinflamm. 2022 Feb 21;9(3):e1148. doi: 10.1212/NXI.0000000000001148. Print 2022 May.
Neurol Neuroimmunol Neuroinflamm. 2022.
PMID: 35190477
Free PMC article.
Clinical Trial.
Item in Clipboard
Multiple sclerosis: progression rate and severity in a multicenter cohort from Algeria.
Hecham N, Nouioua S, Sifi Y, Toubal N, Aissa LA, Hattab S, Batsi D, Hamimed A, Berkane F, Oudrer N, Aidi A, Abrouk S, Daoudi S, Hamri A, Assami S, Tazir M.
Hecham N, et al.
Mult Scler. 2014 Dec;20(14):1923-4. doi: 10.1177/1352458514543343. Epub 2014 Aug 13.
Mult Scler. 2014.
PMID: 25122474
No abstract available.
Item in Clipboard
Cite
Cite